Donaldson E - Search Results

1

Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation.

Chan-Tack K, Harrington P, Bensman T, Choi SY, Donaldson E, O'Rear J, McMillan D, Myers L, Seaton M, Ghantous H, Cao Y, Valappil T, Birnkrant D, Struble K. Chan-Tack K, et al. Among authors: donaldson e. Antiviral Res. 2021 Nov;195:105182. doi: 10.1016/j.antiviral.2021.105182. Epub 2021 Sep 25. Antiviral Res. 2021. PMID: 34582915 Review.

2

Impact of hepatitis C virus polymorphisms on direct-acting antiviral treatment efficacy: Regulatory analyses and perspectives.

Harrington PR, Komatsu TE, Deming DJ, Donaldson EF, O'Rear JJ, Naeger LK. Harrington PR, et al. Among authors: donaldson ef. Hepatology. 2018 Jun;67(6):2430-2448. doi: 10.1002/hep.29693. Hepatology. 2018. PMID: 29194682

3

In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products.

Komatsu TE, Hodowanec AC, Colberg-Poley AM, Pikis A, Singer ME, O'Rear JJ, Donaldson EF. Komatsu TE, et al. Among authors: donaldson ef. Antiviral Res. 2019 Sep;169:104549. doi: 10.1016/j.antiviral.2019.104549. Epub 2019 Jul 4. Antiviral Res. 2019. PMID: 31279814 Clinical Trial.

4

Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir.

Donaldson EF, Harrington PR, O'Rear JJ, Naeger LK. Donaldson EF, et al. Hepatology. 2015 Jan;61(1):56-65. doi: 10.1002/hep.27375. Epub 2014 Nov 20. Hepatology. 2015. PMID: 25123381

5

Regulatory evaluation of antiviral drug resistance in the era of next-generation sequencing.

Donaldson EF, Deming DJ, O'Rear JJ, Naeger LK. Donaldson EF, et al. Biomark Med. 2015;9(11):1047-51. doi: 10.2217/bmm.15.63. Epub 2015 Oct 28. Biomark Med. 2015. PMID: 26508693 Free article. No abstract available.

6

FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.

Mishra P, Florian J, Qi K, Zeng W, Naeger LK, Donaldson E, Connelly S, O'Rear J, Price D, Murray J, Birnkrant D. Mishra P, et al. Among authors: donaldson e. Gastroenterology. 2014 Dec;147(6):1196-200. doi: 10.1053/j.gastro.2014.10.027. Epub 2014 Oct 27. Gastroenterology. 2014. PMID: 25449024 No abstract available.

7

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.

Ilyushina NA, Komatsu TE, Ince WL, Donaldson EF, Lee N, O'Rear JJ, Donnelly RP. Ilyushina NA, et al. Among authors: donaldson ef. Virol J. 2019 Nov 29;16(1):149. doi: 10.1186/s12985-019-1258-x. Virol J. 2019. PMID: 31783761 Free PMC article.

8

Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus.

Anderson RT, Lim SG, Mishra P, Josephson F, Donaldson E, Given B, Miller V. Anderson RT, et al. Among authors: donaldson e. Gastroenterology. 2019 Feb;156(3):529-533.e4. doi: 10.1053/j.gastro.2018.11.062. Epub 2018 Dec 4. Gastroenterology. 2019. PMID: 30529300 Review. No abstract available.

9

Communicating regulatory high-throughput sequencing data using BioCompute Objects.

King CHS 4th, Keeney J, Guimera N, Das S, Weber M, Fochtman B, Walderhaug MO, Talwar S, Patel JA, Mazumder R, Donaldson EF. King CHS 4th, et al. Drug Discov Today. 2022 Apr;27(4):1108-1114. doi: 10.1016/j.drudis.2022.01.007. Epub 2022 Jan 22. Drug Discov Today. 2022. PMID: 35077912 Review.

10

2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation.

Mbala-Kingebeni P, Pratt CB, Wiley MR, Diagne MM, Makiala-Mandanda S, Aziza A, Di Paola N, Chitty JA, Diop M, Ayouba A, Vidal N, Faye O, Faye O, Karhemere S, Aruna A, Nsio J, Mulangu F, Mukadi D, Mukadi P, Kombe J, Mulumba A, Duraffour S, Likofata J, Pukuta E, Caviness K, Bartlett ML, Gonzalez J, Minogue T, Sozhamannan S, Gross SM, Schroth GP, Kuhn JH, Donaldson EF, Delaporte E, Sanchez-Lockhart M, Peeters M, Muyembe-Tamfum JJ, Alpha Sall A, Palacios G, Ahuka-Mundeke S. Mbala-Kingebeni P, et al. Among authors: donaldson ef. Lancet Infect Dis. 2019 Jun;19(6):641-647. doi: 10.1016/S1473-3099(19)30124-0. Epub 2019 Apr 15. Lancet Infect Dis. 2019. PMID: 31000465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page